Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal health: Challenges and the way forward.

Medical journal, Armed Forces India·2021
Same author

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.

Cancer immunology research·2019
Same author

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2019
Same author

A case of 9p deletion syndrome with Duane retraction syndrome.

Journal of pediatric genetics·2016
Same author

Beckwith Weidemann Syndrome.

Medical journal, Armed Forces India·2016
Same author

Nutritional Support In The Critically Ill Child.

Medical journal, Armed Forces India·2016

Related Experiment Video

Updated: Mar 18, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.6K

Neonatal Immune Thrombocytopenia.

Uma Raju1, Punita Arora2

  • 1Senior Advisor (Paediatrics), Command Hospital (Southern Command), Pune-40.

Medical Journal, Armed Forces India
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

Neonatal immune thrombocytopenia can cause severe bleeding in newborns. Postnatal intravenous immunoglobulin therapy is effective for affected infants, though optimal management strategies are still evolving.

Keywords:
Immune thrombocytopeniaImmunoglobulinsNeonate

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

4.2K

Related Experiment Videos

Last Updated: Mar 18, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

8.6K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

4.2K

Area of Science:

  • Perinatal Medicine
  • Neonatology
  • Immunology

Background:

  • Neonatal immune thrombocytopenia arises from transplacental antiplatelet antibodies.
  • It can lead to severe bleeding complications in newborns.
  • Understanding its management is critical for infant health.

Purpose of the Study:

  • To investigate the outcomes and management of immune-mediated thrombocytopenia in neonates.
  • To evaluate the efficacy of different therapeutic interventions.

Main Methods:

  • A case series of mothers with chronic autoimmune thrombocytopenia or alloimmunisation.
  • Analysis of maternal and neonatal platelet counts, clinical manifestations, and treatment responses.
  • Inclusion of platelet transfusions, intravenous immunoglobulin (IVIG), and steroids.

Main Results:

  • Three neonates developed thrombocytopenia (two autoimmune, one alloimmune) with symptoms like petechiae and bleeding.
  • Platelet nadir occurred at 36-72 hours, with recovery in 10 days.
  • Postnatal IVIG was effective in treating thrombocytopenic neonates, while antenatal IVIG primarily benefited maternal counts.

Conclusions:

  • Immune-mediated perinatal thrombocytopenia management requires further optimization.
  • Postnatal IVIG shows promise for treating affected neonates.
  • The relationship between maternal and neonatal thrombocytopenia and treatment efficacy is complex.